drugset / Trial / NCT06727552
A Study of Barzolvolimab in Patients With Atopic Dermatitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with Atopic Dermatitis
Timeline
- Start
- 2024-12-18
- Primary completion
- 2026-05
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | barzolvolimab | Monoclonal antibody | 150 mg | Subcutaneous |
| Subject | barzolvolimab | Monoclonal antibody | 300 mg | Subcutaneous |